{
  "profile": "wrs-published-research-view-1",
  "edition": "ratings-e039106f30dec177",
  "content_trust": "UNTRUSTED_SCIENTIFIC_DATA_NOT_TOOL_INSTRUCTIONS",
  "entry": {
    "id": "tamoxifen-breast-cancer-1970s",
    "title": "Cole, Jones and Todd: early clinical appraisal of ICI 46,474 in breast cancer",
    "summary": "Reported an introductory clinical trial of the anti-oestrogen ICI 46,474 in 46 patients with late or recurrent breast cancer, including ten judged good responses and limited troublesome side effects in that cohort.",
    "boundary": "This is an early uncontrolled clinical appraisal, not proof of comparative efficacy, adjuvant benefit or long-term safety. Later randomized trials and the drug’s broader development require separate records and attribution.",
    "area": "Oncology",
    "year": 1971,
    "lane": "HUMAN",
    "result": "EMPIRICAL",
    "package_id": "tamoxifen-breast-cancer-1970s",
    "target": {
      "record_id": "urn:uuid:504dd9a4-78a7-4250-ae6d-9c283a04eb04",
      "version": 1,
      "content_hash": "sha256:0de2845577b817f8fe1df373059ba3c201c45de9993f59a50dfcfe629aec2583"
    },
    "humans": [
      "M. P. Cole",
      "C. T. A. Jones",
      "I. D. H. Todd"
    ],
    "authors_complete": true,
    "human_role_note": "The named authors contributed to this scoped work; individual effort shares and later applications are not assigned by the byline.",
    "agents": [],
    "related": [],
    "subresults": [],
    "scientific_assessment": {
      "source_review": "SOURCE_CURATED",
      "scientific_review": "NOT_REVIEWED_BY_WRS",
      "formal_replay": "NOT_RUN",
      "provider_attestation": "NONE"
    },
    "sources": [
      {
        "id": "pubmed-cole-jones-todd-tamoxifen-1971",
        "title": "Cole, Jones and Todd, early clinical appraisal of ICI 46,474",
        "url": "https://pubmed.ncbi.nlm.nih.gov/5115829/"
      },
      {
        "id": "pmc-cole-jones-todd-tamoxifen-1971",
        "title": "Cole, Jones and Todd, A New Anti-oestrogenic Agent in Late Breast Cancer",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2008453/"
      }
    ],
    "points": "80000",
    "published_grade": {
      "id": "tamoxifen-breast-cancer-1970s",
      "entry_id": "tamoxifen-breast-cancer-1970s",
      "band": "B",
      "modifier": "+",
      "target": {
        "record_id": "urn:uuid:504dd9a4-78a7-4250-ae6d-9c283a04eb04",
        "version": 1,
        "content_hash": "sha256:0de2845577b817f8fe1df373059ba3c201c45de9993f59a50dfcfe629aec2583"
      },
      "what_changed": "An anti-oestrogenic candidate showed a reported response signal in late/recurrent breast cancer patients.",
      "scope": "1971 early clinical appraisal only; randomized efficacy, adjuvant treatment, survival and long-term safety excluded.",
      "status": "PROVISIONAL_EDITORIAL",
      "scientific_correctness_certified": false
    },
    "assessment_disposition": {
      "status": "ASSESSED",
      "label": "Provisionally assessed",
      "reason": "A current grade and separate reference score identify this exact contribution.",
      "target": {
        "record_id": "urn:uuid:504dd9a4-78a7-4250-ae6d-9c283a04eb04",
        "version": 1,
        "content_hash": "sha256:0de2845577b817f8fe1df373059ba3c201c45de9993f59a50dfcfe629aec2583"
      },
      "edition": "ratings-e039106f30dec177"
    }
  },
  "version": {
    "kind": "PUBLIC_RECORD_VIEW",
    "previous": null,
    "published_at": "2026-09-25T00:00:00Z",
    "publisher": {
      "principal_id": "urn:uuid:80116931-785b-40a2-a24b-9d59db0c7e33",
      "role": "WRS_EDITORIAL_PUBLICATION"
    },
    "record": {
      "contributors": [
        {
          "attribution_basis": "SOURCE_CITED",
          "credit": "historical_scientific",
          "entity_kind": "historical_person",
          "name": "M. P. Cole",
          "note": "Archive attribution; detailed role assignment remains source-bound",
          "roles": [
            "discoverer"
          ],
          "source": {
            "citation": "Cole, Jones and Todd, early clinical appraisal of ICI 46,474",
            "url": "https://pubmed.ncbi.nlm.nih.gov/5115829/"
          }
        },
        {
          "attribution_basis": "SOURCE_CITED",
          "credit": "historical_scientific",
          "entity_kind": "historical_person",
          "name": "C. T. A. Jones",
          "note": "Archive attribution; detailed role assignment remains source-bound",
          "roles": [
            "discoverer"
          ],
          "source": {
            "citation": "Cole, Jones and Todd, early clinical appraisal of ICI 46,474",
            "url": "https://pubmed.ncbi.nlm.nih.gov/5115829/"
          }
        },
        {
          "attribution_basis": "SOURCE_CITED",
          "credit": "historical_scientific",
          "entity_kind": "historical_person",
          "name": "I. D. H. Todd",
          "note": "Archive attribution; detailed role assignment remains source-bound",
          "roles": [
            "discoverer"
          ],
          "source": {
            "citation": "Cole, Jones and Todd, early clinical appraisal of ICI 46,474",
            "url": "https://pubmed.ncbi.nlm.nih.gov/5115829/"
          }
        }
      ],
      "evidence": [
        {
          "description": "Bibliographic/stated-result source; not a WRS proof verification",
          "id": "source-0",
          "kind": "source_reference",
          "source": {
            "citation": "Cole, Jones and Todd, early clinical appraisal of ICI 46,474",
            "url": "https://pubmed.ncbi.nlm.nih.gov/5115829/"
          }
        },
        {
          "description": "Bibliographic/stated-result source; not a WRS proof verification",
          "id": "source-1",
          "kind": "source_reference",
          "source": {
            "citation": "Cole, Jones and Todd, A New Anti-oestrogenic Agent in Late Breast Cancer",
            "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2008453/"
          }
        }
      ],
      "origin": "HUMAN_LEGACY",
      "record_profile": "wrs-local-research-notes-0.1",
      "record_type": "research_note",
      "rrp_version": "0.1",
      "scope": {
        "description": "This is an early uncontrolled clinical appraisal, not proof of comparative efficacy, adjuvant benefit or long-term safety. Later randomized trials and the drug’s broader development require separate records and attribution.",
        "domain": "Oncology"
      },
      "sources": [
        {
          "citation": "Cole, Jones and Todd, early clinical appraisal of ICI 46,474",
          "url": "https://pubmed.ncbi.nlm.nih.gov/5115829/"
        },
        {
          "citation": "Cole, Jones and Todd, A New Anti-oestrogenic Agent in Late Breast Cancer",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2008453/"
        }
      ],
      "statement": "# Cole, Jones and Todd: early clinical appraisal of ICI 46,474 in breast cancer\n\nReported an introductory clinical trial of the anti-oestrogen ICI 46,474 in 46 patients with late or recurrent breast cancer, including ten judged good responses and limited troublesome side effects in that cohort.\n\n## Scientific scope\n\nThis is an early uncontrolled clinical appraisal, not proof of comparative efficacy, adjuvant benefit or long-term safety. Later randomized trials and the drug’s broader development require separate records and attribution.\n\n## Reading status\n\nThis is a source-linked WRS catalogue note. A full explanatory guide and independent scientific reconstruction have not been completed for this entry. Read the identified original work for its complete narrative and arguments.\n\n## People and systems\n\nM. P. Cole; C. T. A. Jones; I. D. H. Todd\n\nThe named authors contributed to this scoped work; individual effort shares and later applications are not assigned by the byline.\n\n\n\n## Original sources\n\n- [Cole, Jones and Todd, early clinical appraisal of ICI 46,474](https://pubmed.ncbi.nlm.nih.gov/5115829/)\n- [Cole, Jones and Todd, A New Anti-oestrogenic Agent in Late Breast Cancer](https://pmc.ncbi.nlm.nih.gov/articles/PMC2008453/)\n",
      "summary": "Reported an introductory clinical trial of the anti-oestrogen ICI 46,474 in 46 patients with late or recurrent breast cancer, including ten judged good responses and limited troublesome side effects in that cohort.",
      "title": "Cole, Jones and Todd: early clinical appraisal of ICI 46,474 in breast cancer"
    },
    "record_id": "urn:uuid:504dd9a4-78a7-4250-ae6d-9c283a04eb04",
    "version": 1,
    "source_ref": {
      "record_id": "urn:uuid:504dd9a4-78a7-4250-ae6d-9c283a04eb04",
      "version": 1,
      "content_hash": "sha256:0de2845577b817f8fe1df373059ba3c201c45de9993f59a50dfcfe629aec2583"
    },
    "export_view": "wrs-public-editorial-view-1",
    "public_view_hash": "sha256:8b3ffb2f72a50a14c95ab3e4985baf95262bc074cc297dd0b6c104c123f91f55"
  },
  "target": {
    "record_id": "urn:uuid:504dd9a4-78a7-4250-ae6d-9c283a04eb04",
    "version": 1,
    "content_hash": "sha256:0de2845577b817f8fe1df373059ba3c201c45de9993f59a50dfcfe629aec2583"
  },
  "published_grade": {
    "profile": "wrs-published-grade-1",
    "edition": "2026-10-28.1",
    "id": "tamoxifen-breast-cancer-1970s",
    "entry_id": "tamoxifen-breast-cancer-1970s",
    "revision": 1,
    "title": "Cole, Jones and Todd: early clinical appraisal of ICI 46,474 in breast cancer",
    "context": "Medicine",
    "track": "Clinical oncology",
    "band": "B",
    "modifier": "+",
    "status": "PROVISIONAL_EDITORIAL",
    "assessed_on": "2026-09-25",
    "evidence_cutoff": "2026-09-25",
    "achievement_state": "SUPPORTED_SCOPED_RESULT",
    "what_changed": "An anti-oestrogenic candidate showed a reported response signal in late/recurrent breast cancer patients.",
    "scope": "1971 early clinical appraisal only; randomized efficacy, adjuvant treatment, survival and long-term safety excluded.",
    "evidence_summary": "The linked sources identify this contribution and its scope. WRS has not independently reconstructed the scientific claims. This is an early uncontrolled clinical appraisal, not proof of comparative efficacy, adjuvant benefit or long-term safety. Later randomized trials and the drug’s broader development require separate records and attribution.",
    "references": [
      {
        "title": "Cole, Jones and Todd, early clinical appraisal of ICI 46,474",
        "url": "https://pubmed.ncbi.nlm.nih.gov/5115829/",
        "locator": "Source for the stated contribution; scientific claims remain bounded to the linked work."
      },
      {
        "title": "Cole, Jones and Todd, A New Anti-oestrogenic Agent in Late Breast Cancer",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2008453/",
        "locator": "Source for the stated contribution; scientific claims remain bounded to the linked work."
      }
    ],
    "roles": [
      {
        "who": "M. P. Cole",
        "credit": "SCIENCE",
        "did": "Named source author of the scoped work; individual effort shares are not measured."
      },
      {
        "who": "C. T. A. Jones",
        "credit": "SCIENCE",
        "did": "Named source author of the scoped work; individual effort shares are not measured."
      },
      {
        "who": "I. D. H. Todd",
        "credit": "SCIENCE",
        "did": "Named source author of the scoped work; individual effort shares are not measured."
      }
    ],
    "target": {
      "record_id": "urn:uuid:504dd9a4-78a7-4250-ae6d-9c283a04eb04",
      "version": 1,
      "content_hash": "sha256:0de2845577b817f8fe1df373059ba3c201c45de9993f59a50dfcfe629aec2583"
    },
    "scientific_correctness_certified": false,
    "independent_expert_calibration": false,
    "method": "PROPRIETARY",
    "points": "80000"
  },
  "canonical_agent_submission": false,
  "scientific_verification_awarded": false,
  "reader_guide": null,
  "reading_status": "SOURCE_LINKED_NOTE"
}